Corpus Intelligence IC Memo — TIDELANDS HEALTH REHABILITATION HOSP 2026-04-26 10:39 UTC
IC Memo — TIDELANDS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | SC | 75 beds | Grade C | EBITDA uplift $2.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TIDELANDS HEALTH REHABILITATION HOSP

CCN 423033 | GEORGETOWN, SC | 75 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TIDELANDS HEALTH REHABILITATION HOSP is a 75-bed community hospital in GEORGETOWN, SC with $35.6M in net patient revenue and a 23.5% operating margin. The hospital serves a payer mix of 82.3% Medicare, 0.0% Medicaid, and 17.7% commercial.

Thesis: Turnaround. Our ML models identify $2.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 23.5% to 30.9% (+736bps).

Net Revenue HCRIS$35.6M
Current EBITDA COMPUTED$8.4M
Operating Margin COMPUTED23.5%
Occupancy HCRIS75.5%
Revenue / Bed COMPUTED$474K
Net-to-Gross HCRIS69.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
44
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of 23.5% places it above the state median. Among 44 size-comparable peers (38-150 beds), the median margin is 6.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-150), prioritizing same-state peers. 44 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TIDELANDS HEALTH REHABILITATIO (Target)SC75$35.6M23.5%
PH PATEWOOD HOSPITALSC64$229.8M38.0%
EAST COOPER REGIONAL MEDICAL CSC120$206.1M28.3%
OCONEE MEMORIAL HOSPITALSC131$190.4M5.2%
WACCAMAW COMMUNITY HOSPITALSC124$182.8M2.7%
GEORGETOWN MEMORIAL HOSPITALSC68$168.0M-4.6%
HILTON HEAD HOSPITALSC109$165.7M29.2%
PH GREER MEMORIAL HOSPITALSC66$161.3M31.3%
PH BAPTIST PARKRIDGE HOSPITALSC78$159.8M18.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$747K+210bp18mo
Cost to Collect4.5%2.5%$712K+200bp12mo
Denial Rate Reduction12.0%6.5%$704K+198bp12mo
A/R Days Reduction5200.0%3800.0%$433K+122bp9mo
Clean Claim Rate88.0%96.0%$23K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$747K
Cost to Collect
$712K
Denial Rate Reduction
$704K
A/R Days Reduction
$433K
Clean Claim Rate
$23K
Total EBITDA Uplift$2.6M
Current EBITDA$8.4M
+ RCM Uplift+$2.6M
Pro Forma EBITDA$11.0M
Current Margin23.5%
Pro Forma Margin30.9%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$12.9M$81.4M6.32x44.6%
Base (11x exit)10.0x11.0x$12.9M$93.8M7.28x48.7%
Bull Case9.0x11.0x$11.6M$106.6M9.19x55.8%
Bull (12x exit)9.0x12.0x$11.6M$119.7M10.32x59.5%
Bear Case11.0x10.0x$14.2M$64.1M4.53x35.2%
Bear (11x exit)11.0x11.0x$14.2M$75.2M5.30x39.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 82.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 44 hospitals with 38-150 beds
  • Same-state prioritization (n=45)
  • Comp margins: P25=-6.0% / P50=6.7% / P75=17.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.